341 related articles for article (PubMed ID: 8723601)
1. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
Fresco C; Proclemer A; Pavan A; Buia G; Vicentini A; Pavan D; Morgera T
Clin Cardiol; 1996 May; 19(5):409-12. PubMed ID: 8723601
[TBL] [Abstract][Full Text] [Related]
2. Intravenous propafenone for converting recent onset atrial fibrillation in emergency departments: a randomized placebo-controlled multicenter trial. FAPS Investigators Study Group.
Ganau G; Lenzi T
J Emerg Med; 1998; 16(3):383-7. PubMed ID: 9610964
[TBL] [Abstract][Full Text] [Related]
3. Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.
Bianconi L; Mennuni M
Am J Cardiol; 1998 Sep; 82(5):584-8. PubMed ID: 9732884
[TBL] [Abstract][Full Text] [Related]
4. Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.
Bellandi F; Dabizzi RP; Cantini F; Natale MD; Niccoli L
Cardiovasc Drugs Ther; 1996 May; 10(2):153-7. PubMed ID: 8842507
[TBL] [Abstract][Full Text] [Related]
5. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.
Capucci A; Villani GQ; Aschieri D; Piepoli M
Int J Cardiol; 1999 Feb; 68(2):187-96. PubMed ID: 10189007
[TBL] [Abstract][Full Text] [Related]
6. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.
Madonia S; De Simone M; Brai G; Gozzo D; Gristina A; Luciano L; Maisano S; Migliore G; Mineo R; Muzzo MP; Nicchi F; Randazzo A; Raspanti G; Rotolo G; Russo A; Sagona F; Schirosa M; Spinello M; Stancampiano R; Geraci E
Ital Heart J; 2000 Jul; 1(7):475-9. PubMed ID: 10933330
[TBL] [Abstract][Full Text] [Related]
7. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.
Stroobandt R; Stiels B; Hoebrechts R
Am J Cardiol; 1997 Feb; 79(4):418-23. PubMed ID: 9052343
[TBL] [Abstract][Full Text] [Related]
8. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
[TBL] [Abstract][Full Text] [Related]
9. Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review.
Hughes C; Sunderji R; Gin K
Can J Cardiol; 1997 Sep; 13(9):839-42. PubMed ID: 9343033
[TBL] [Abstract][Full Text] [Related]
10. Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study.
Azpitarte J; Alvarez M; Baún O; García R; Moreno E; Martín F; Tercedor L; Fernández R
Eur Heart J; 1997 Oct; 18(10):1649-54. PubMed ID: 9347277
[TBL] [Abstract][Full Text] [Related]
11. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial.
Boriani G; Biffi M; Capucci A; Botto GL; Broffoni T; Rubino I; Della Casa S; Sanguinetti M; Magnani B
Ann Intern Med; 1997 Apr; 126(8):621-5. PubMed ID: 9103129
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological cardioversion with intravenous propafenone in atrial fibrillation].
Velázquez Rodríguez E; Cancino Rodríguez C; Arias Estrada S; Rangel Rojo J; Hernández Morales E; Uribe Muñoz A
Arch Inst Cardiol Mex; 2000; 70(2):160-6. PubMed ID: 10932801
[TBL] [Abstract][Full Text] [Related]
13. Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation.
Zapolski T; Wysokiński A
Kardiol Pol; 2005 Sep; 63(3):254-62; discussion 263-4. PubMed ID: 16180181
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
[TBL] [Abstract][Full Text] [Related]
16. Oral loading with propafenone: a placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation.
Boriani G; Biffi M; Capucci A; Botto GL; Broffoni T; Rubino I; Della Casa S; Sanguinetti M; Branzi A; Magnani B
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2465-9. PubMed ID: 9825368
[TBL] [Abstract][Full Text] [Related]
17. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
Bellandi F; Dabizzi RP; Niccoli L; Cantini F; Palchetti R
G Ital Cardiol; 1996 Apr; 26(4):379-90. PubMed ID: 8707022
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of antazoline vs propafenone for conversion of paroxysmal atrial fibrillation to sinus rhythm: a randomized, double-blind study (AnProAF).
Karwowski J; Wrzosek K; Mączyńska-Mazuruk R; Szmarowska K; Rekosz J; Wiktorska A; Mierzejewska B; Solecki M; Dłużniewski M
Pol Arch Intern Med; 2024 Apr; 134(4):. PubMed ID: 38166357
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
Lee SH; Chen SA; Chiang CE; Tai CT; Wen ZC; Wang SP; Chang MS
J Intern Med; 1996 Mar; 239(3):253-60. PubMed ID: 8772625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
